Basilea Pharmaceutica AG
Basilea Pharmaceutica AG (BSLN.SW) Stock Competitors & Peer Comparison
See (BSLN.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BSLN.SW | CHF 54.70 | +0.55% | 671.3M | 17.42 | CHF 3.14 | N/A |
| GILD.SW | CHF 110.83 | -3.44% | 137.6B | 20.62 | CHF 5.38 | +2.30% |
| BION.SW | CHF 44.40 | -0.11% | 2.4B | 4.21 | CHF 10.54 | +5.07% |
| MOR.SW | CHF 102.00 | +0.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| KURN.SW | CHF 23.24 | +4.40% | 910.5M | 387.33 | CHF 0.06 | N/A |
| IDIA.SW | CHF 3.61 | +4.03% | 720.5M | -6.94 | -CHF 0.52 | N/A |
| NWRN.SW | CHF 15.50 | +2.24% | 310.2M | -25.41 | -CHF 0.61 | N/A |
| SANN.SW | CHF 16.38 | +5.27% | 230.2M | -3.04 | -CHF 5.38 | N/A |
| MOLN.SW | CHF 3.05 | -2.24% | 114.1M | -1.85 | -CHF 1.65 | N/A |
| MMTX.SW | CHF 0.35 | +8.02% | 53.4M | N/A | N/A | N/A |
Stock Comparison
BSLN.SW vs GILD.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, GILD.SW has a market cap of 137.6B. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while GILD.SW trades at CHF 110.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas GILD.SW's P/E ratio is 20.62. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to GILD.SW's ROE of +0.26%. Regarding short-term risk, BSLN.SW is more volatile compared to GILD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for BSLN.SW.Check GILD.SW's competition here
BSLN.SW vs BION.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, BION.SW has a market cap of 2.4B. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while BION.SW trades at CHF 44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas BION.SW's P/E ratio is 4.21. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to BION.SW's ROE of -0.13%. Regarding short-term risk, BSLN.SW is less volatile compared to BION.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check BION.SW's competition here
BSLN.SW vs MOR.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while MOR.SW trades at CHF 102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to MOR.SW's ROE of -1.84%. Regarding short-term risk, Volatility data is not available for a full comparison. BSLN.SW has daily volatility of 1.81 and MOR.SW has daily volatility of N/A.Check MOR.SW's competition here
BSLN.SW vs KURN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, KURN.SW has a market cap of 910.5M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while KURN.SW trades at CHF 23.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas KURN.SW's P/E ratio is 387.33. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to KURN.SW's ROE of +0.02%. Regarding short-term risk, BSLN.SW is less volatile compared to KURN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check KURN.SW's competition here
BSLN.SW vs IDIA.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, IDIA.SW has a market cap of 720.5M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while IDIA.SW trades at CHF 3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas IDIA.SW's P/E ratio is -6.94. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to IDIA.SW's ROE of +0.10%. Regarding short-term risk, BSLN.SW is less volatile compared to IDIA.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check IDIA.SW's competition here
BSLN.SW vs NWRN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, NWRN.SW has a market cap of 310.2M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while NWRN.SW trades at CHF 15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas NWRN.SW's P/E ratio is -25.41. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to NWRN.SW's ROE of +2.78%. Regarding short-term risk, BSLN.SW is less volatile compared to NWRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check NWRN.SW's competition here
BSLN.SW vs SANN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, SANN.SW has a market cap of 230.2M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while SANN.SW trades at CHF 16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas SANN.SW's P/E ratio is -3.04. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to SANN.SW's ROE of -5.22%. Regarding short-term risk, BSLN.SW is less volatile compared to SANN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check SANN.SW's competition here
BSLN.SW vs MOLN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, MOLN.SW has a market cap of 114.1M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while MOLN.SW trades at CHF 3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas MOLN.SW's P/E ratio is -1.85. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to MOLN.SW's ROE of -0.60%. Regarding short-term risk, BSLN.SW is less volatile compared to MOLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check MOLN.SW's competition here
BSLN.SW vs MMTX.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, MMTX.SW has a market cap of 53.4M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while MMTX.SW trades at CHF 0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas MMTX.SW's P/E ratio is N/A. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to MMTX.SW's ROE of N/A. Regarding short-term risk, BSLN.SW is less volatile compared to MMTX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check MMTX.SW's competition here
BSLN.SW vs RLF.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, RLF.SW has a market cap of 36.3M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while RLF.SW trades at CHF 2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas RLF.SW's P/E ratio is -2.12. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to RLF.SW's ROE of -0.49%. Regarding short-term risk, BSLN.SW is less volatile compared to RLF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check RLF.SW's competition here
BSLN.SW vs ADXN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, ADXN.SW has a market cap of 6M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while ADXN.SW trades at CHF 0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas ADXN.SW's P/E ratio is -0.67. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to ADXN.SW's ROE of -0.78%. Regarding short-term risk, BSLN.SW is less volatile compared to ADXN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check ADXN.SW's competition here
BSLN.SW vs EVE.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, EVE.SW has a market cap of 6M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while EVE.SW trades at CHF 0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas EVE.SW's P/E ratio is -6.92. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to EVE.SW's ROE of -0.13%. Regarding short-term risk, BSLN.SW is less volatile compared to EVE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check EVE.SW's competition here
BSLN.SW vs SPEX.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, BSLN.SW is less volatile compared to SPEX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check SPEX.SW's competition here
BSLN.SW vs OBSN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, BSLN.SW is less volatile compared to OBSN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check OBSN.SW's competition here
BSLN.SW vs POLN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, BSLN.SW is less volatile compared to POLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check POLN.SW's competition here
BSLN.SW vs SKIN.SW Comparison April 2026
BSLN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSLN.SW stands at 671.3M. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, BSLN.SW is priced at CHF 54.70, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSLN.SW currently has a P/E ratio of 17.42, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, BSLN.SW's ROE is +0.28%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, BSLN.SW is less volatile compared to SKIN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BSLN.SW.Check SKIN.SW's competition here